Telehealth-enhanced hybrid cardiac rehabilitation versus clinic-based rehab after an acute coronary syndrome
Official title: Comparing a Novel Telehealth-enabled Hybrid Cardiac Rehabilitation Program to Clinic-based Cardiac Rehabilitation for Improving Patient Engagement and Functional Outcomes After ACS
Run by Columbia University · NCT07541014 · Data updated 2026-11-12
This trial tests whether TeleheartCR, a hybrid program combining telehealth, home, and clinic sessions, helps people who had an acute coronary syndrome complete cardiac rehab and improve their fitness as well as traditional clinic-based rehab.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 19, 2026 |
| Main results expected | May 2029 |
| Study ends | May 2029 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT07541014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older who had an acute coronary syndrome within the past 12 months, are eligible for outpatient cardiac rehabilitation, can read English or Spanish, and live in New York State are ideal candidates.
✕Probably not a fit
People with high exercise-related cardiovascular risk, severe medical or psychiatric comorbidities, unsafe home environments, those who already started cardiac rehab, or those living outside New York State are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares a TeleheartCR hybrid program (up to 36 sessions delivered via a mix of clinic-based and home/telehealth sessions, typically over about 12 weeks) with traditional clinic-based cardiac rehabilitation in patients who experienced an acute coronary syndrome. The study's primary implementation outcome is program adherence, and the primary effectiveness outcome is non-inferior pre-to-post change in functional capacity; secondary outcomes include quality of life and cardiorespiratory fitness. Participants are adults (≥18) within 12 months of ACS, able to read English or Spanish, and residing in New York State; some clinic visits at Columbia University Irving Medical Center are required. The protocol allows scheduling flexibility with up to 6 months post-enrollment to complete the program to accommodate clinical and personal needs.
Why it matters
Potential benefit: If successful, TeleheartCR could increase access and adherence to cardiac rehabilitation while preserving the same functional and quality-of-life benefits as clinic-based programs.
How similar studies have gone: Previous studies of home-based or telehealth cardiac rehab have shown promising or non-inferior results for fitness and adherence, though hybrid programs focused on implementation and equity are less extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Diagnosis of acute coronary syndrome within the past 12 months * Eligible for outpatient cardiac rehabilitation * Able to read and speak English or Spanish * Resides in New York State Exclusion Criteria: * Severe medical or psychiatric comorbidities that would prevent safe or adequate participation * High risk for adverse exercise-related cardiovascular events * Initiation of cardiac rehabilitation prior to enrollment (i.e., \>1 session completed) * Conditions that would interfere with safe or consistent participation in study procedures * Home environment or willingness not compatible with safe or adequate participation * Not expected to be available for follow-up during the study period * Current participation in another interventional clinical trial that may affect study outcomes
Where it's running
-
Columbia University Irving Medical Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Andrea T. Duran, PhD — Columbia University
- Study coordinator: Andrea T Duran, PhD
- Email: atd2127@cumc.columbia.edu
- Phone: 212-342-4491
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Digital cardiac rehab to help heart attack patients improve function
A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Innate Immune Cells and Early Fibrotic Repair After a Heart Attack
This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.